DISTRIBUSI PENGGUNAAN BERAGAM JENIS VAKSIN COVID-19 DI WILAYAH KERJA PUSKESMAS GENTUNGAN, DESA GENTUNGAN, KECAMATAN BAJENG BARAT, KABUPATEN GOWA TAHUN 2022

In December 2019, Wuhan City in Hubei Province, China, became the epicenter of a novel coronavirus outbreak, later identified as SARS-CoV-2, the causative agent of COVID-19. Common symptoms of COVID-19 infection include fever, cough, and shortness of breath. This study aimed to determine the percentage distribution of various COVID-19 vaccine types administered at the Gentungan Public Health Center. Employing a non-experimental, descriptive approach, this research analyzed existing data without intervention on test subjects, utilizing a retrospective data collection method. The study population comprised 9,000 individuals, from which a sample of 383 participants was selected. The results indicated the following distribution of vaccine usage: Sinovac was administered to 236 individuals (61.61%), Pfizer to 61 individuals (15.92%), Moderna to 53 individuals (13.83%), and AstraZeneca to 33 individuals (8.61%). Sinovac was the most frequently administered vaccine, likely due to its ample availability and the lack of choice afforded to the public regarding vaccine selection.

Authors

Institutions

Publication Details

Journal
Jurnal Kesehatan Yamasi Makassar
Published
2025-07-30
DOI
https://doi.org/10.59060/jurkes.v9i2.396
Primary Topic
COVID-19 Prevention and Impact
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

DISTRIBUSI PENGGUNAAN BERAGAM JENIS VAKSIN COVID-19 DI WILAYAH KERJA PUSKESMAS GENTUNGAN, DESA GENTUNGAN, KECAMATAN BAJENG BARAT, KABUPATEN GOWA TAHUN 2022

A Tenriugi Daeng Pine, Hernawati Basir, Yuyun Wahyuni, Istiana Purnamasari et al.
Jurnal Kesehatan Yamasi Makassar
COVID-19 Prevention and Impact
article

DISTRIBUSI PENGGUNAAN BERAGAM JENIS VAKSIN COVID-19 DI WILAYAH KERJA PUSKESMAS GENTUNGAN, DESA GENTUNGAN, KECAMATAN BAJENG BARAT, KABUPATEN GOWA TAHUN 2022

A Tenriugi Daeng Pine, Hernawati Basir, Yuyun Wahyuni, Istiana Purnamasari, Delvi SJP
article en

Abstract

In December 2019, Wuhan City in Hubei Province, China, became the epicenter of a novel coronavirus outbreak, later identified as SARS-CoV-2, the causative agent of COVID-19. Common symptoms of COVID-19 infection include fever, cough, and shortness of breath. This study aimed to determine the percentage distribution of various COVID-19 vaccine types administered at the Gentungan Public Health Center. Employing a non-experimental, descriptive approach, this research analyzed existing data without intervention on test subjects, utilizing a retrospective data collection method. The study population comprised 9,000 individuals, from which a sample of 383 participants was selected. The results indicated the following distribution of vaccine usage: Sinovac was administered to 236 individuals (61.61%), Pfizer to 61 individuals (15.92%), Moderna to 53 individuals (13.83%), and AstraZeneca to 33 individuals (8.61%). Sinovac was the most frequently administered vaccine, likely due to its ample availability and the lack of choice afforded to the public regarding vaccine selection.

Jurnal Kesehatan Yamasi MakassarVol. 9(2)
Muhammadiyah University of Makassar (ID)
Openalex Percentile: Top 74%
COVID-19 Prevention and Impact
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.